Dimensional Fund Advisors LP boosted its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 0.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,991,652 shares of the company's stock after purchasing an additional 12,967 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.49% of Colgate-Palmolive worth $373,995,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of CL. Brighton Jones LLC lifted its position in shares of Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after acquiring an additional 450 shares in the last quarter. Bernard Wealth Management Corp. purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at $36,000. Main Street Financial Solutions LLC lifted its position in shares of Colgate-Palmolive by 38.8% in the fourth quarter. Main Street Financial Solutions LLC now owns 5,681 shares of the company's stock valued at $516,000 after acquiring an additional 1,587 shares in the last quarter. Marshall Wace LLP purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at $24,830,000. Finally, CANADA LIFE ASSURANCE Co lifted its position in shares of Colgate-Palmolive by 1.7% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 916,683 shares of the company's stock valued at $83,313,000 after acquiring an additional 15,747 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
CL has been the topic of several recent research reports. Citigroup reduced their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, August 4th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, August 4th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Finally, UBS Group cut their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Seven analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $98.92.
View Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Stock Up 1.7%
NYSE CL traded up $1.4590 during mid-day trading on Tuesday, reaching $85.7190. 4,548,147 shares of the company's stock traded hands, compared to its average volume of 5,225,339. Colgate-Palmolive Company has a 1-year low of $82.40 and a 1-year high of $109.30. The company has a fifty day simple moving average of $88.07 and a 200-day simple moving average of $89.98. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company has a market cap of $69.28 billion, a price-to-earnings ratio of 24.08, a P/E/G ratio of 4.42 and a beta of 0.35.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 EPS. As a group, equities research analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a $0.52 dividend. The ex-dividend date was Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.43%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.